Table 1.
Clinical and laboratory characteristics of the sample
| Frequency | % | |
|---|---|---|
| N | 148 | 100 |
| Sex | ||
| Male | 84 | 57 |
| Female | 64 | 43 |
| Estimated age (years) | ||
| 0–2 | 16/106 | 15 |
| 3–5 | 73/106 | 69 |
| ≥ 6 | 17/106 | 16 |
| Size | ||
| Small | 36/146 | 25 |
| Medium | 85/146 | 58 |
| Large | 25/146 | 17 |
| Clinical category | ||
| Asymptomatic | 15 | 10 |
| Symptomatic | 133 | 90 |
| ELISA | ||
| Negative | 27 | 18 |
| Positive | 118 | 80 |
| Grey zone | 3 | 2 |
| Culture | ||
| Negative | 81 | 55 |
| Positive | 67 | 45 |
| PCR | ||
| Negative | 8/135 | 6 |
| Positive | 127/135 | 94 |
| Leishmanin skin test | ||
| Negative | 75/85 | 88 |
| Positive | 10/85 | 12 |
| Positive in one test | 35 | 24 |
| Positive in all tests | 52 | 35 |
| Co-infections | ||
| Ehrlichiosis | 39/57 | 68 |
| Babesiosis | 12/56 | 21 |
| Positive ELISA results | ||
| Asymptomatic | 10 | 67 |
| Symptomatic | 112 | 84 |
| Positive culture results | ||
| Asymptomatic | 3 | 20 |
| Symptomatic | 65 | 49 |
Abbreviation: N, absolute number. The denominator varies according to the availability of the recorded data